Healthcare -
Biotechnology - NASDAQ - US
$ 15.49
-7.91 %
$ 475 M
Market Cap
-2.56
P/E
ANAB - TOTAL CURRENT LIABILITIES
Total Current Liabilities ANAB - AnaptysBio, Inc.
37.4 M
LAST VALUE
52.50%
2 YEAR CAGR
11.39%
5 YEAR CAGR
28.04%
10 YEAR CAGR